Preliminary Efficacy and Tolerability of NCX-1000 After Repeated Oral Doses in Patients With Elevated Portal Pressure

NCT00414869 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
INDUSTRY
Sponsor class

Stopped Preliminary analysis of 11 patients did not demonstrate the efficacy required.

Conditions

Interventions

Sponsor

Forest Laboratories